m-HBOT represents a lower pressurized chamber, generally under 1.5 ATA, and typically at 1.3 ATA. These lower atmospheric pressures (representing roughly only 10 feet below sea level) allow for greater safety, while still allowing for the delivery of much higher levels of oxygen into the tissues. The FDA has cleared m-HBOT as an approved treatment for those suffering from altitude sickness, where oxygen levels can become dangerously low at higher elevations — a condition that is life threatening. The extra oxygen delivered through m-HBOT is so significant that it can be enough to help reverse this life threatening condition.
WHAT IS MILD HYPERBARIC OXYGEN THERAPY (m-HBOT)?